Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 1 Interventional Accepts healthy volunteers

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

ClinicalTrials.gov ID: NCT07086677

Public ClinicalTrials.gov record NCT07086677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN STUDY TO DESCRIBE THE SAFETY AND TOLERABILITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn about the safety and tolerability of a pneumococcal vaccine in adults. Participants will receive either: * an experimental PG4 vaccine * a PG4 vaccine comparator * a standard 20vPnC vaccine comparator * placebo. A placebo does not have any medicine in it but looks just like the study medicine. Participants will take part in this study for up to 18 months depending on which group they are assigned to. During this time, the participants will receive up to two doses of study vaccine or comparator and take part in follow-up visits. At these clinic visits, participants will be asked if any side effects were experienced. The participants will also have to give blood samples during clinic visits.

Study identification

NCT ID
NCT07086677
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
380 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years to 84 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 21, 2025
Primary completion
Oct 20, 2027
Completion
Oct 20, 2027
Last update posted
Jun 21, 2026

2025 – 2027

United States locations

U.S. sites
20
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Orange County Research Center Lake Forest California 92630
Peninsula Research Associates Rolling Hills Estates California 90274
Finlay Medical Research Greenacres City Florida 33467
Indago Research & Health Center, Inc. Miami Lakes Florida 33016
Johnson County Clinical Trials Lenexa Kansas 66219
Bio-Kinetic Clinical Applications, LLC dba QPS-MO Springfield Missouri 65802
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center Springfield Missouri 65807
Bio-Kinetic Clinical Applications, LLC dba QPS-MO Springfield Missouri 65807
Velocity Clinical Research, Omaha Omaha Nebraska 68134
Upstate Global Health Institute East Syracuse New York 13057
NYU Langone Health Vaccine Center New York New York 10016
Duke Vaccine and Trials Unit Durham North Carolina 27703
CTI Clinical Research Center Cincinnati Ohio 45212
Headlands Horizons, LLC dba Headlands Research-Brownsville Brownsville Texas 78526
Valley Regional Medical Center Brownsville Texas 78526
LabCorp Houston Texas 77064
IMA Clinical Research San Antonio San Antonio Texas 78229
Dynamed Clinical Research, LP d/b/a DM Clinical Research Tomball Texas 77375
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07086677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07086677 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →